Diaxonhit Aktie
25,35EUR | 0,10EUR | 0,40% |
WKN DE: A2DVTN / ISIN: FR0013240934
Aktionärsstruktur
Inhaber | in % |
---|---|
Eb Development Holding | 51,00 |
Freefloat | 30,10 |
Jean-Michel Carle Grandmougin | 15,12 |
EchiumBio Holding BV | 9,96 |
Eurobio-Scientific SA | 8,78 |
Oddo BHF Asset Management SAS | 1,64 |
Amplégest PME | 1,15 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 0 | 0 | 169 | 0 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 1,09 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 40 | 135 | 173 | 148 | 143 |
Summe Anlagevermögen | 41 | 37 | 36 | 182 | 172 |
Summe Aktiva | 81 | 172 | 209 | 330 | 316 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 46 | 65 | 49 | 158 | 141 |
Summe Eigenkapital | 35 | 107 | 160 | 172 | 175 |
Summe Passiva | 81 | 172 | 209 | 330 | 316 |
Adresse
ZA de Courtaboeuf, 91953 Les Ulis | |
Telefon | +33 (1) 69-79-64-80 |
Internet | http://www.eurobio-scientific.fr |
Management
Cathie Marsais
Chief Operating Officer & Deputy CEO |
Denis Fortier
Chairman & Chief Executive Officer |
Grégoire Sentilhes
Director |
Hanneke Merkens
Chief Marketing & Communication Officer |
Hervé Duchesne de Lamotte
Director & Deputy Chief Executive Officer |
Jacques Martin
Vice President-Marketing |
Jean-Michel Carle Grandmougin
Director & Deputy Chief Executive Officer |
Maarten Penning
Chief Technology Officer |
Michel Picot
Independent Director |
Olivier Bosc
CFO & Head-Information Technology |
Patrick de Roquemaurel
Independent Director |
Thomas Moreaux
Chief Human Resources Officer |